ICU Medical, Inc.

Equities

ICUI

US44930G1076

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq Other stock markets 04:00:00 2024-04-26 pm EDT			5-day change	1st Jan Change
94.84 ^USD	+0.33%		-0.97%	-4.91%

Mar. 20	Transcript : ICU Medical, Inc. Presents at KeyBanc Capital Markets Virtual Life Sciences & MedTech Investor Forum, Mar-20-2024 02:15 PM
Mar. 15	Icu Medical Inc/de Insider Sold Shares Worth $812,741, According to a Recent SEC Filing	MT

ICU Medical, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023

February 27, 2024 at 04:11 pm EST

ICU Medical, Inc. reported earnings results for the fourth quarter ended December 31, 2023. For the fourth quarter, the company reported sales was USD 587.86 million compared to USD 578.01 million a year ago. Net loss was USD 17.15 million compared to USD 15.54 million a year ago.

Basic loss per share from continuing operations was USD 0.71 compared to USD 0.65 a year ago. Diluted loss per share from continuing operations was USD 0.71 compared to USD 0.65 a year ago.

Latest news about ICU Medical, Inc.

Transcript : ICU Medical, Inc. Presents at KeyBanc Capital Markets Virtual Life Sciences & MedTech Investor Forum, Mar-20-2024 02:15 PM	Mar. 20
Icu Medical Inc/de Insider Sold Shares Worth $812,741, According to a Recent SEC Filing	Mar. 15	MT
Icu Medical Insider Sold Shares Worth $4,386,155, According to a Recent SEC Filing	Mar. 11	MT
ICU Medical, Inc. Announces the Resignation of Bill Seeger as Nominated Director	Mar. 07	CI
Icu Medical Insider Sold Shares Worth $1,458,090, According to a Recent SEC Filing	Mar. 05	MT
Transcript : ICU Medical, Inc. Presents at 45th Annual Raymond James Institutional Investors Conference 2024, Mar-04-2024 07:30 AM	Mar. 04
Smiths Group Confirms $88 Million Sale of ICU Medical Stake	Mar. 01	MT
ICU Medical, Inc. Announces Resignation of William Seeger from Board of Director and Member of the Audit and Compliance Committee	Feb. 29	CI
An unknown buyer completed the acquisition of 3.44% stake in ICU Medical, Inc. (NasdaqGS : ICUI) from Smiths Group International Holdings Ltd. for $88.042 million.	Feb. 28	CI
KeyBanc Adjusts Price Target on ICU Medical to $136 From $134, Maintains Overweight Rating	Feb. 28	MT
ICU Medical's Q4 Adjusted Earnings Decline While Revenue Increases; Sets 2024 Adjusted Profit Guidance	Feb. 28	MT
ICU Medical, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 27	CI
Transcript : ICU Medical, Inc., Q4 2023 Earnings Call, Feb 27, 2024	Feb. 27
Earnings Flash (ICUI) ICU MEDICAL Reports Q4 Revenue $587.9M, vs. Street Est of $568.3M	Feb. 27	MT
Earnings Flash (ICUI) ICU MEDICAL Reports Q4 EPS $1.57, vs. Street Est of $1.19	Feb. 27	MT
ICU Medical, Inc. Provides Earnings Guidance for the Fiscal Year 2024	Feb. 27	CI
ICU Medical, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Feb. 27	CI
CL King Starts ICU Medical With Buy Rating, $110 Price Target	Dec. 14	MT
Icu Medical Insider Sold Shares Worth $152,196, According to a Recent SEC Filing	Dec. 01	MT
ICU Medical, Inc.(NasdaqGS:ICUI) added to S&P 600 Health Care	Nov. 30	CI
ICU Medical, Inc.(NasdaqGS:ICUI) added to S&P 600	Nov. 30	CI
ICU Medical, Inc.(NasdaqGS:ICUI) dropped from S&P 400 Health Care	Nov. 30	CI
ICU Medical, Inc.(NasdaqGS:ICUI) dropped from S&P 400	Nov. 30	CI
Sector Update: Financial Stocks Edge Higher Late Afternoon	Nov. 28	MT
Sector Update: Financial Stocks Higher Tuesday Afternoon	Nov. 28	MT

Chart ICU Medical, Inc.

Duration

Period

More charts

Company Profile

ICU Medical, Inc. develops, manufactures, and sells medical products used in infusion therapy, vascular access, and vital care applications. Its product portfolio includes ambulatory, syringe, and large volume IV pumps and safety software; dedicated and non-dedicated IV sets, needle free IV connectors, peripheral IV catheters, and sterile IV solutions; closed system transfer devices and pharmacy compounding systems; as well as a range of respiratory, anesthesia, patient monitoring, and temperature management products. Its Infusion Therapy products include Clave needlefree products, Neutron, and Tego. Its oncology products include ChemoLock Closed System Transfer Devices (CSTD) and Deltec GRIPPER non-coring needles for portal access. Its vascular access products include Safe-T Wing venipuncture and blood collection devices; Port-A-Cath implantable port, and Portex arterial blood sampling syringes. Its Tracheostomy product include Portex BLUselect PVC tracheostomy tubes.

Sector

Medical Equipment, Supplies & Distribution

Calendar

2024-05-07 - Q1 2024 Earnings Release

More about the company

Income Statement Evolution

More financial data

Ratings for ICU Medical, Inc.

Trading Rating

Investor Rating

ESG Refinitiv

C+

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

94.84 USD

Average target price

142.2 USD

Spread / Average Target

+49.99%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Medical Equipment, Supplies & Distribution

	1st Jan change	Capi.
ICU MEDICAL, INC.	-4.91%	2.31B
ABBOTT LABORATORIES	-2.31%	187B
MEDTRONIC PLC	-3.20%	106B
BECTON, DICKINSON AND COMPANY	-5.04%	66.9B
DEXCOM, INC.	+0.20%	49.45B
CENCORA, INC.	+17.29%	48B
HOYA CORPORATION	+4.06%	40.84B
METTLER-TOLEDO INTERNATIONAL, INC.	+2.07%	26.48B
WEST PHARMACEUTICAL SERVICES, INC.	+2.36%	26.25B
TERUMO CORPORATION	+12.96%	24.62B

Other Medical Equipment, Supplies & Distribution